HK2 and rheumatoid arthritis: Interestingly, inhibition of JAK/STAT3 signaling with Tofacinib, a drug approved for severe RA and active psoriasis, induces oxidative phosphorylation and maximal respiratory capacity of FLS while shutting down key glycolytic enzymes including HK2 and LDHA [83].